Posts tagged IONS


Top Analyst Shares Two Cents on Ionis Pharmaceuticals Inc (IONS) Following FAP Trial Results

Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares are tumbling nearly 11% in Monday’s trading session, after the …

Read more

Company Update (NASDAQ:IONS): Here’s Why Ionis Pharmaceuticals Inc Shares Rising 4%

Ionis Pharmaceuticals Inc (NASDAQ:IONS) reported that it outperformed its financial guidance by ending 2016 with pro …

Read more

Stock Update (NASDAQ:IONS): Ionis Pharmaceuticals Inc Earns $75 Million from Bayer for Advancing IONIS-FXI Rx and IONIS-FXI-L Rx

Ionis Pharmaceuticals, Inc. (NASDAQ:IONS) announced the advancement of IONIS-FXIRx  in clinical development under an existing …

Read more

Stock Update (NASDAQ:IONS): Ionis Pharmaceuticals Inc Expects to Outclass Original 2016 Financial Guidance

Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced that the Company expects to significantly improve upon its 2016 …

Read more

Ionis Pharmaceuticals Inc (IONS), Akcea Strike Favorable Deal with Novartis AG (ADR) (NVS): Cowen Top Analyst

Ionis Pharmaceuticals Inc (NASDAQ:IONS) shares were initially up 6% this morning after the biotech firm …

Read more

Company Update (NASDAQ:IONS): Ionis Pharmaceuticals Inc and Akcea Enter into Strategic Global Collaboration with Novartis; Shares Rise 6%

Ionis Pharmaceuticals Inc (NASDAQ:IONS) and Akcea Therapeutics, a wholly-owned subsidiary of Ionis, announced an exclusive, …

Read more

Stock Update (NASDAQ:IONS): Ionis Pharmaceuticals Inc Reports Positive Data from Phase 2 Study in Patients with Type 2 Diabetes

Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced positive data from a Phase 2 study of IONIS-GCGRRx in …

Read more

Chardan Bullish on AveXis Inc (AVXS) Following Rival Spinraza Broad-Label Approval

Chardan analyst Gbola Amusa is placing his confidence behind AveXis Inc (NASDAQ:AVXS) even in light …

Read more

Leerink Swann Boosts Price Target on Ionis Pharmaceuticals Inc (IONS); Here’s Why

Following the news that Ionis Pharmaceuticals Inc (NASDAQ: IONS) has secured FDA approval in a major way …

Read more

Stock Update (NASDAQ:IONS): Ionis Pharmaceuticals Inc Earns Milestone Payment from Janssen for Advancing a New Program Under GI Collaboration

Ionis Pharmaceuticals Inc (NASDAQ:IONS) announced today that it has earned $5 million milestone payment from …

Read more